These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35093871)

  • 61. Adjuvant Oral Recombinant Methioninase Inhibits Lung Metastasis in a Surgical Breast-Cancer Orthotopic Syngeneic Model.
    Sugisawa N; Hamada K; Han Q; Yamamoto J; Sun YU; Nishino H; Kawaguchi K; Bouvet M; Unno M; Hoffman RM
    Anticancer Res; 2020 Sep; 40(9):4869-4874. PubMed ID: 32878774
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Overexpression and large-scale production of recombinant L-methionine-alpha-deamino-gamma-mercaptomethane-lyase for novel anticancer therapy.
    Tan Y; Xu M; Tan X; Tan X; Wang X; Saikawa Y; Nagahama T; Sun X; Lenz M; Hoffman RM
    Protein Expr Purif; 1997 Mar; 9(2):233-45. PubMed ID: 9056489
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Overcoming High Trabectedin Resistance of Soft-tissue Sarcoma With Recombinant Methioninase: A Potential Solution of a Recalcitrant Clinical Problem.
    Morinaga S; Han Q; Mizuta K; Kang BM; Sato M; Bouvet M; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Higuchi T; Tsuchiya H; Demura S; Hoffman RM
    Anticancer Res; 2024 Sep; 44(9):3785-3791. PubMed ID: 39197928
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chloroquine Combined With Rapamycin Arrests Tumor Growth in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Dedifferentiated Liposarcoma.
    Masaki N; Aoki Y; Kubota Y; Obara K; Miyazaki J; Hoffman RM
    In Vivo; 2022; 36(6):2630-2637. PubMed ID: 36309387
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model.
    Sato M; Mizuta K; Han Q; Morinaga S; Kang BM; Kubota Y; Mori R; Baranov A; Kobayashi K; Ardjmand D; Kobayashi N; Bouvet M; Ichikawa Y; Nakajima A; Hoffman RM
    In Vivo; 2024; 38(3):1058-1063. PubMed ID: 38688611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Osteosarcoma Patient-derived Orthotopic Xenograft (PDOX) Models Used to Identify Novel and Effective Therapeutics: A Review.
    Higuchi T; Igarashi K; Yamamoto N; Hayashi K; Kimura H; Miwa S; Bouvet M; Tsuchiya H; Hoffman RM
    Anticancer Res; 2021 Dec; 41(12):5865-5871. PubMed ID: 34848441
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral Installation of Recombinant Methioninase-producing
    Kubota Y; Han Q; Hamada K; Aoki Y; Masaki N; Obara K; Baranov A; Bouvet M; Tsunoda T; Hoffman RM
    Cancer Genomics Proteomics; 2022; 19(6):683-691. PubMed ID: 36316039
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Miyake K; Murakami T; Kiyuna T; Igarashi K; Kawaguchi K; Li Y; Singh AS; Dry SM; Eckardt MA; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Endo I; Eilber FC; Hoffman RM
    J Cell Biochem; 2018 Jan; 119(1):967-972. PubMed ID: 28681998
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment.
    Miki K; Al-Refaie W; Xu M; Jiang P; Tan Y; Bouvet M; Zhao M; Gupta A; Chishima T; Shimada H; Makuuchi M; Moossa AR; Hoffman RM
    Cancer Res; 2000 May; 60(10):2696-702. PubMed ID: 10825143
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recombinant-methioninase-producing
    Kubota Y; Han Q; Morinaga S; Mizuta K; Bouvet M; Tsunoda T; Hoffman RM
    Cancer Diagn Progn; 2023; 3(6):649-654. PubMed ID: 37927811
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model.
    Yamamoto J; Miyake K; Han Q; Tan Y; Inubushi S; Sugisawa N; Higuchi T; Tashiro Y; Nishino H; Homma Y; Matsuyama R; Chawla SP; Bouvet M; Singh SR; Endo I; Hoffman RM
    Cancer Lett; 2020 Nov; 492():174-184. PubMed ID: 32739322
    [TBL] [Abstract][Full Text] [Related]  

  • 72. First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease.
    Sato M; Han Q; Hozumi C; Kujiraoka H; Mizuta K; Morinaga S; Kang BM; Kobayashi N; Ichikawa Y; Nakajima A; Hoffman RM
    Anticancer Res; 2024 Sep; 44(9):3885-3889. PubMed ID: 39197890
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs.
    Hu J; Cheung NK
    Int J Cancer; 2009 Apr; 124(7):1700-6. PubMed ID: 19089915
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models.
    Kawaguchi K; Han Q; Li S; Tan Y; Igarashi K; Miyake K; Kiyuna T; Miyake M; Chemielwski B; Nelson SD; Russell TA; Dry SM; Li Y; Singh AS; Eckardt MA; Unno M; Eilber FC; Hoffman RM
    Oncotarget; 2018 Feb; 9(13):11119-11125. PubMed ID: 29541401
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Review: Precise sarcoma patient-derived orthotopic xenograft (PDOX) mouse models enable identification of novel effective combination therapies with the cyclin-dependent kinase inhibitor palbociclib: A strategy for clinical application.
    Higuchi T; Igarashi K; Yamamoto N; Hayashi K; Kimura H; Miwa S; Bouvet M; Tsuchiya H; Hoffman RM
    Front Oncol; 2022; 12():957844. PubMed ID: 36003796
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pioglitazone, an agonist of PPARĪ³, reverses doxorubicin-resistance in an osteosarcoma patient-derived orthotopic xenograft model by downregulating P-glycoprotein expression.
    Higuchi T; Sugisawa N; Miyake K; Oshiro H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Kline Z; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
    Biomed Pharmacother; 2019 Oct; 118():109356. PubMed ID: 31545293
    [TBL] [Abstract][Full Text] [Related]  

  • 77. miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells.
    Bazavar M; Fazli J; Valizadeh A; Ma B; Mohammadi E; Asemi Z; Alemi F; Maleki M; Xing S; Yousefi B
    Pathol Res Pract; 2020 Nov; 216(11):153176. PubMed ID: 32861171
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Novel Procedure for Orthotopic Tibia Implantation for Establishment of a More Clinical Osteosarcoma PDOX Mouse Model.
    Wu NF; Yamamoto J; Bouvet M; Hoffman RM
    In Vivo; 2021; 35(1):105-109. PubMed ID: 33402455
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recombinant Methioninase Is Selectively Synergistic With Doxorubicin Against Wild-type Fibrosarcoma Cells Compared to Normal Cells and Overcomes Highly-Doxorubicin-resistant Fibrosarcoma.
    Morinaga S; Han Q; Mizuta K; Kang BM; Sato M; Bouvet M; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Higuchi T; Tsuchiya H; Demura S; Hoffman RM
    Anticancer Res; 2024 Aug; 44(8):3261-3268. PubMed ID: 39060039
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.
    Murakami T; Singh AS; Kiyuna T; Dry SM; Li Y; James AW; Igarashi K; Kawaguchi K; DeLong JC; Zhang Y; Hiroshima Y; Russell T; Eckardt MA; Yanagawa J; Federman N; Matsuyama R; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
    Oncotarget; 2016 Jul; 7(30):47556-47564. PubMed ID: 27286459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.